NYSE - Delayed Quote ? USD Edwards Lifesciences Corporation (EW) Follow Compare 69.38 -0.97 (-1.38%) At close: October 25 at 4:00 PM EDT 69.01 -0.37 (-0.53%) After hours: October 25 at 7:50 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Earnings Beat: Edwards Lifesciences Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Edwards Lifesciences Corporation ( NYSE:EW ) came out with its third-quarter results last week, and we wanted to see... Simply Wall St. ? 13 hours ago EW -1.38% Edwards Skids On Weak Expectations For Its Bread-And-Butter Moneymaker Edwards Lifesciences stock fell Friday after the company said its TAVR segment will face numerous challenges in the fourth quarter. Investor's Business Daily ? yesterday EW -1.38% EW Q3 Earnings Match Estimates, Revenues Miss, Stock Falls Edwards Lifesciences reports strong contributions from all of the product groups - TAVR, TTMT and surgical structural heart - in the third quarter of 2024. Zacks ? yesterday EW -1.38% Edwards Lifesciences Corp (EW) Q3 2024 Earnings Call Highlights: Strong Growth in TMTT Sales ... Edwards Lifesciences Corp (EW) reports robust Q3 performance with significant growth in Transcatheter Mitral and Tricuspid Therapies, despite facing operational challenges and competitive pressures. GuruFocus.com ? yesterday EW -1.38% Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. Zacks ? 2 days ago EW -1.38% Edwards Lifesciences: Q3 Earnings Snapshot EW) on Thursday reported third-quarter earnings of $3.07 billion. On a per-share basis, the Irvine, California-based company said it had net income of $5.13. Earnings, adjusted for one-time gains and costs, were 67 cents per share. Associated Press Finance ? 2 days ago EW -1.38% Edwards Lifesciences Reports Third Quarter Results IRVINE, Calif., October 24, 2024--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Sept. 30, 2024. Business Wire ? 2 days ago EW -1.38% Here’s Why Edwards Lifesciences Corporation (EW) Detracted Wedgewood Partners, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, Wedgewood Composite’s net return was 5.8% compared to the Standard & Poor’s 5.9%, the Russell 1000 Growth Index’s 3.2%, and the Russell 1000 Value Index’s 9.4% return for the same period. […] Insider Monkey ? 2 days ago EW -1.38% TFX or EW: Which Is the Better Value Stock Right Now? TFX vs. EW: Which Stock Is the Better Value Option? Zacks ? 3 days ago EW -1.38% TFX Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an... Simply Wall St. ? 4 days ago EW -1.38% Boston Scientific, Edwards and Dexcom usher in second week of earnings Johnson & Johnson, Abbott and Intuitive Surgical made a mixed start to earnings season last week. MedTech Dive ? 4 days ago BSX -0.43% EW -1.38% JNJ Edwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. Zacks ? 5 days ago EW -1.38% Investors in Edwards Lifesciences (NYSE:EW) have unfortunately lost 41% over the last three years Many investors define successful investing as beating the market average over the long term. But if you try your hand... Simply Wall St. ? 8 days ago EW -1.38% Earnings Preview: DexCom (DXCM) Q3 Earnings Expected to Decline DexCom (DXCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Zacks ? 9 days ago DXCM -1.88% EW -1.38% Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024 IRVINE, Calif., October 17, 2024--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2024 after the market closes on Thursday, October 24, 2024, and will host a conference call at 5:30 p.m. ET that day to discuss those results. Business Wire ? 9 days ago EW -1.38% Artisan Mid Cap Fund Sold Edwards Lifesciences Corporation (EW) as it Failed to Meet Growth Expectations Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return of 2.38%, and Institutional Class fund APHMX returned 2.40%, compared […] Insider Monkey ? 10 days ago EW -1.38% Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q3 Release Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Zacks ? 10 days ago EW -1.38% Edwards Lifesciences to Report Q3 Earnings: What's in the Cards? EW is likely to have witnessed continued growth in TAVR procedures across the United States and worldwide in the third quarter. Zacks ? 12 days ago EW -1.38% Great week for Edwards Lifesciences Corporation (NYSE:EW) institutional investors after losing 2.4% over the previous year Key Insights Given the large stake in the stock by institutions, Edwards Lifesciences' stock price might be vulnerable... Simply Wall St. ? 15 days ago EW -1.38% Edwards Lifesciences Soars on TTVR Approval, But Challenges Remain Medical device company Edward Lifesciences sees stock jump on milestone, but upcoming divestiture raises concerns GuruFocus.com ? 18 days ago EW -1.38% Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return EW S&P 500 YTD -9.01% +21.77% 1-Year -1.57% +36.74% 3-Year -40.49% +27.79%
